Sigma Group
3
44M
3
0.08
1
- Areas of investment
Summary
In 1986 was created Sigma Group, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Saddle River. The company was established in North America in United States.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany. Among the most popular portfolio startups of the fund, we may highlight CureVac.
The standard case for the fund is to invest in rounds with 7 partakers. Despite the Sigma Group, startups are often financed by dievini Hopp Biotech Holding, Bill & Melinda Gates Foundation. The meaningful sponsors for the fund in investment in the same round are dievini Hopp Biotech Holding, Northview LifeSciences, Coppel Family. In the next rounds fund is usually obtained by Landeskreditbank Baden-Wu00fcrttemberg, LBBW Asset Management, Baden-Wu00fcrttembergische Versorgungsanstalt fu00fcr u00c4rzte.
The typical startup value when the investment from Sigma Group is more than 1 billion dollars. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2015.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.08
- Investments by industry
- Biotechnology (3)
- Pharmaceutical (2)
- Medical (1)
- Health Care (1)
- Therapeutics (1) Show 3 more
- Investments by region
-
- Germany (1)
- United States (1)
- United Kingdom (1)
- Peak activity year
- 2023
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 548M
- Group Appearance index
- 1.00
- Strategy success index
- 0.38
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ten63 Therapeutics | 02 May 2023 | Biotechnology, Health Care, Medical, Pharmaceutical | Early Stage Venture | 15M | United States, North Carolina, Durham |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.